Ascorbate-Meglumine
Asset
Formulation of ascorbic acid acting as an antioxidant or pro-oxidant.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Oxidative stress and ROS signalling
- 0
- Indications
- 261
- Trials
- 1
- Developer
Indications
1No named disease
Phase 1, Unknown, NCT06433791, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Trials261
- Evidence for its targets3
- Competitors1
- Aging relevance1
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.